Medicine: Off the Market

"Out of an abundance of caution," read the letter from Cincinnati's Wm. S. Merrell Co. to 230,000 U.S. physicians, "we have determined that the sale of tripara-nol should be discontinued until all possible controversy is put to rest." Thus last week almost half a million patients learned that they could no longer hope to cut down the cholesterol circulating in their blood — and perhaps reduce the danger of heart attacks — simply by swallowing a daily 35^ triparanol capsule.

Triparanol (trade name: MER/29) was marketed two years ago with only a background...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!